Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32860307&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community #MMPMID32860307
Strauss AT; Cartier D; Gunning BA; Boyarsky BJ; Snyder J; Segev DL; Roush M; Massie AB
Am J Transplant 2020[Nov]; 20 (11): 3123-3130 PMID32860307show ga
Many deceased-donor and living-donor kidney transplants (KTs) rely on commercial airlines for transport. However, the coronavirus-19 pandemic has drastically impacted the commercial airline industry. To understand potential pandemic-related disruptions in the transportation network of kidneys across the United States, we used national flight data to compare scheduled flights during the pandemic vs 1-year earlier, focusing on Organ Procurement Organization (OPO) pairs between which kidneys historically most likely traveled by direct flight (High Volume by direct Air transport OPO Pairs, HVA-OPs). Across the United States, there were 39% fewer flights in April 2020 vs April 2019. Specific to the kidney transportation network, there were 65.1% fewer flights between HVA-OPs, with considerable OPO-level variation (interquartile range [IQR] 54.7%-75.3%; range 0%-100%). This translated to a drop in median number of flights between HVA-OPs from 112 flights/wk in April 2019 to 34 in April 2020 (P < .001), and a rise in wait time between scheduled flights from 1.5 hours in April 2019 (IQR 0.76-3.3) to 4.9 hours in April 2020 (IQR 2.6-11.2; P < .001). Fewer flights and longer wait times can impact logistics as well as cold ischemia time; our findings motivate an exploration of creative approaches to KT transport as the impact of this pandemic on the airline industry evolves.
|*Pandemics[MESH]
|Aircraft/*statistics & numerical data[MESH]
|COVID-19/*epidemiology[MESH]
|Comorbidity[MESH]
|Female[MESH]
|Humans[MESH]
|Kidney Transplantation/*methods[MESH]
|Male[MESH]
|Renal Insufficiency/epidemiology/*surgery[MESH]
|Retrospective Studies[MESH]
|SARS-CoV-2[MESH]
|Tissue Donors/*supply & distribution[MESH]
|Tissue and Organ Procurement/*organization & administration[MESH]